Introduction Wuhan Optics Valley Vcanbiopharma Co., Ltd. is a wholly-owned subsidiary of Consun Pharmaceutical Group Co., Ltd., established to focus on the development of new cell-based drugs. Vcanbiopharma Co. Ltd. is a publicly traded company with a core business in stem cell and gene engineering. The company drives growth through a dual-core approach and operates across three main divisions: precision prevention, precision diagnostics, and cell therapy. Its primary business activities span cell testing, preparation, and storage; the research, production, and sales of in vitro diagnostic raw materials, reagents, and devices; and the development of research reagents like biological genes, proteins, antibodies, gene testing services, as well as the R&D of clinical applications for stem and immune cells as part of a "precision medicine" industry chain. |